INO
NASDAQ
$1.10
Inovio Pharmaceuticals Inc (INO)
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $3.43 (+212.09%)
Market Cap
$82M
Beta (5Y)
1.20
Price Chart
Valuation
Market Cap$82M
Forward P/E16.58
P/S1712.37
P/B15.73
Profitability
Gross Profit (TTM)-$52M
EBITDA-$82M
EPS-$1.72
Growth & Risk
EPS 5Y CAGR-33.33%
FCF 5Y CAGR-16.59%
Beta (5Y)1.20
Sharpe Ratio0.08